Biotech firm I-Mab to divest China operations amid US shift

Biotech firm I-Mab to divest China operations amid US shift

Laboratory equipment. Photo: Pixabay

I-Mab said on Wednesday it has agreed to divest its operations and assets in China as part of its strategy to become a U.S.-focused biotech firm, sending the company’s shares up nearly 11% in premarket trading.